Selexys Pharmaceuticals
Oklahoma City, US · Delaware corporation · 1 known investors
Founders & leadership
SR
Scott Rollins, Ph.D.Founder
DF
David FalconerinExecutive
RA
Richard AlvarezinExecutive
RR
Russell RotherinExecutive
RM
Rodger McEver, M.D.Named on SEC filing
Board
PJ
Philip Jones, M.D.Board director
TF
Todd FoleyBoard director
DK
David KeiserBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 1 round · 2012
▶$43.2MraisedFeb 2015 · 57 investors · BiotechnologyRule 506(b)
▶$43.2MraisedFeb 2015 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David FalconerExecutive Officer
- Philip Jones, M.D.Director
- David KeiserDirector
- Richard AlvarezExecutive Officer
- Todd FoleyDirector
- Russell RotherExecutive Officer
- Rodger McEver, M.D.Director
- Scott Rollins, Ph.D.Executive Officer, Director
- Offering amount
- $43.2M
- Amount sold
- $43.2M
- Minimum investment
- $13.2K
- Proceeds to insiders
- $4.9M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Selexys Pharmaceuticals?
- Selexys Pharmaceuticals was founded by Scott Rollins, Ph.D..
- Who are Selexys Pharmaceuticals's investors?
- Selexys Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Selexys Pharmaceuticals raised?
- Selexys Pharmaceuticals has disclosed $43.2M raised across 1 round.
- Where is Selexys Pharmaceuticals headquartered?
- Selexys Pharmaceuticals is headquartered in Oklahoma City, US.